GGrantIndex
Sort

16,300 grants matching fatty liver disease

The AMPK/SIRT1 Partnershipand Its Biological Relevance

$343,005
Neil B Ruderman · Boston Medical Center · R01 · FY2014 · DK

Project 3: Conformational Studies of Adducted Oligodeoxynucleotides

$342,940
Michael P Stone · Vanderbilt University · P01 · FY2010 · ES

HEPATIC FATTY ACID METABOLISM AND STEATOSIS

$342,932
Nicholas Davidson · Washington University · R01 · FY2014 · DK

Hepatic mitochondrial oxidative stress, AIDS and alcohol

$342,899
Emory University · R01 · FY2001 · AA

SRC-2 Mediates the Preventative Effects of LRH-1 for NASH in Metabolic Disease

$342,865
David D Moore · Baylor College Of Medicine · P01 · FY2013 · DK

The role of AEG-1 in NASH and NASH-HCC

$342,853
Devanand Sarkar · Virginia Commonwealth University · R01 · FY2018 · DK

DHA Reverses Gene Network Signatures of Fructose-induced Metabolic Syndrome

$342,819
Xia Yang · University Of California Los Angeles · R01 · FY2019 · DK

Monocyte activation and the role of CD11c in obesity-linked metabolic syndrome

$342,751
Huaizhu Wu · Baylor College Of Medicine · R01 · FY2011 · HL

Alcohol-Induced Fatty Liver and Injury in Humanized CYP2E1 Knockin Mice.

$342,749
Arthur I Cederbaum · Icahn School Of Medicine At Mount Sinai · R01 · FY2011 · AA

The role of AEG-1 in NASH and NASH-HCC

$342,705
Devanand Sarkar · Virginia Commonwealth University · R01 · FY2019 · DK

FATTY ACID BINDING PROTEINS-LIGAND SPECIFICITY

$342,676
Friedhelm Schroeder · Texas A&M Agrilife Research · R01 · FY2010 · DK

Thyroid Hormone Action

$342,650
Thomas Sterling Scanlan · Oregon Health & Science University · R01 · FY2012 · DK

Thyroid Hormone Action

$342,650
Thomas Sterling Scanlan · Oregon Health & Science University · R01 · FY2014 · DK

Elucidating the effects of patient weight and metabolic state on circulating nanoparticle efficacy

$342,633
Paul Dalhaimer · University Of Tennessee Knoxville · R15 · FY2015 · GM

Molecular mechanism of omega-3 response

$342,514
James T. Brenna · Cornell University · R01 · FY2015 · AT

AhR-dependent Pkm2 regulation in NAFLD progression

$342,446
Timothy R Zacharewski · Michigan State University · R01 · FY2019 · ES

Nicotine and alcoholic liver disease

$342,429
Yongke Lu · Marshall University · R01 · FY2019 · AA

Nicotine and Alcoholic Liver Disease

$342,429
Yongke Lu · East Tennessee State University · R01 · FY2018 · AA

Nicotine and Alcoholic Liver Disease

$342,429
Yongke Lu · East Tennessee State University · R01 · FY2017 · AA

HGF/HGFR Axis and Fatty Liver Disease

$342,393
Reza Zarnegar · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · AA

HGF/HGFR Axis and Fatty Liver Disease

$342,393
Reza Zarnegar · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · AA

The role of PTEN and AKT2 in the malignant transformation of liver progenitor cel

$342,375
Bangyan Stiles · University Of Southern California · R01 · FY2017 · CA

The role of PTEN and AKT2 in the malignant transformation of liver progenitor cel

$342,375
Bangyan Stiles · University Of Southern California · R01 · FY2016 · CA

AhR-dependent Pkm2 regulation in NAFLD progression

$342,194
Timothy R Zacharewski · Michigan State University · R01 · FY2020 · ES

Regulation of Lipid Storage by mTORC1

$342,157
Dave Bridges · University Of Michigan At Ann Arbor · R01 · FY2017 · DK